Loss of Heterozygosity at 19q13.3 is Associated with Locally Aggressive Neuroblastoma

Overview

Journal Clin Cancer Res

Specialty Oncology

Date 2001 May 15

PMID 11350906

Citations 25

Authors

J Mora

N K Cheung

L Chen

J Qin

W Gerald

Affiliations

Soon will be listed here.

Abstract

A genome-wide allelic analysis of neuroblastoma (NB) revealed a previously undescribed increased incidence of loss of heterozygosity (LOH) on chromosome arm 19q13 primarily affecting stages 3 and 4N disease. Further allelic analysis of chromosome 19q13 in a cohort of 116 NB patients using 17 polymorphic microsatellite markers identified the shortest common region of loss between D19S606 and D19S112 at 19q13.3. In some cases, clonal LOH at 19q13 was acquired during the course of disease, and deleted clones remained after cytotoxic therapy. In multivariant analysis, 19q13 LOH was associated with overall survival in local-regional International Neuroblastoma Staging System stages 1, 2, and 3 patients and was specifically present in tumors at the site of recurrence.

Citing Articles

Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma.

Cha Y, Koo J Int J Mol Sci. 2023; 24(16).

PMID: 37629198 PMC: 10455306. DOI: 10.3390/ijms241613016.

Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma.

Luo Y, Xu M, Yang L, Yao Y, Berry J, Xu L Br J Ophthalmol. 2023; 108(3):449-456.

PMID: 36931696 PMC: 10505245. DOI: 10.1136/bjo-2022-322866.

NCX2 Regulates Intracellular Calcium Homeostasis and Translocation of HIF-1α into the Nucleus to Inhibit Glioma Invasion.

Liu H, Yu J, Yang L, He P, Li Z Biochem Genet. 2022; 61(3):979-994.

PMID: 36334237 PMC: 10199856. DOI: 10.1007/s10528-022-10274-9.

miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.

Holliday H, Yang J, Dodson E, Nikolic I, Kamili A, Wheatley M Mol Ther. 2022; 30(3):1119-1134.

PMID: 34998954 PMC: 8899605. DOI: 10.1016/j.ymthe.2022.01.004.

In vivo Engineering of Chromosome 19 q-arm by Employing the CRISPR/AsCpf1 and ddAsCpf1 Systems in Human Malignant Gliomas (Hypothesis).

Abak A, Shoorei H, Taheri M, Ghafouri-Fard S J Mol Neurosci. 2021; 71(8):1648-1663.

PMID: 33990905 DOI: 10.1007/s12031-021-01855-1.